Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PANAMOL FORTE SYRUP 250 mg/5 ml - HSA Drug Approval Details

Approvals/HSA/PANAMOL FORTE SYRUP 250 mg/5 ml

Approved

THERAPEUTIC

PANAMOL FORTE SYRUP 250 mg/5 ml

BEACONS PHARMACEUTICALS PTE LTD🇸🇬 Health Sciences Authority

Approval Date: May 27, 1991
Approval ID: 15eae0aa1ca66c34
Company: BEACONS PHARMACEUTICALS PTE LTD
Type: Therapeutic

Approval Details

Approval Id: 15eae0aa1ca66c34
Drug Name: PANAMOL FORTE SYRUP 250 mg/5 ml
Product Name: PANAMOL FORTE SYRUP 250 mg/5 ml
Approval Number: SIN06074P
Approval Date: 1991-05-27
Registrant: BEACONS PHARMACEUTICALS PTE. LTD.
Licence Holder: BEACONS PHARMACEUTICALS PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: General Sale List
Dosage Form: SYRUP
Route Of Administration: ORAL
Atc Code: N02BE01
Atc Item Name: paracetamol
Pharma Manufacturer Name: BEACONS PHARMACEUTICALS PTE. LTD.
Company Detail Path: /organization/beacons-pharmaceuticals-pte-ltd

Active Ingredients

PARACETAMOL

250 mg/5 ml

PARACETAMOL

250 MG/5 ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

May 27, 1991

Approval ID

15eae0aa1ca66c34

Type

Therapeutic

Back to HSA Approvals